Literature DB >> 30413853

[White matter alterations after chemotherapy and radiation].

A Simgen1.   

Abstract

Nowadays chemotherapy and radiotherapy are fundamental therapy concepts in the guidelines of malignant tumors of the central nervous system. Both therapy concepts can cause neurological symptoms or white matter alterations can occur, which can be classified into acute, subacute and chronic. Both symptoms and white matter alterations during acute and subacute phases are in most cases completely reversible, whereas chronic white matter alterations can lead to severe neurological limitations and further impair the quality of life of cancer patients.

Entities:  

Keywords:  Brain; Leukoencephalopathies; Magnetic resonance imaging; Nerve fibers; White matter

Mesh:

Year:  2018        PMID: 30413853     DOI: 10.1007/s00117-018-0458-5

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  36 in total

1.  Prospective evaluation of delayed central nervous system (CNS) toxicity of hyperfractionated total body irradiation (TBI).

Authors:  F Wenz; S Steinvorth; F Lohr; S Fruehauf; S Wildermuth; M van Kampen; M Wannenmacher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-12-01       Impact factor: 7.038

2.  Transient posterior encephalopathy induced by chemotherapy in children.

Authors:  R Sánchez-Carpintero; J Narbona; R López de Mesa; J Arbizu; L Sierrasesúmaga
Journal:  Pediatr Neurol       Date:  2001-02       Impact factor: 3.372

Review 3.  Effects of radiation on normal tissue: consequences and mechanisms.

Authors:  Helen B Stone; C Norman Coleman; Mitchell S Anscher; William H McBride
Journal:  Lancet Oncol       Date:  2003-09       Impact factor: 41.316

Review 4.  Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.

Authors:  Avinoam Shuper; Batia Stark; Liora Kornreich; Ian J Cohen; Gali Avrahami; Isaac Yaniv
Journal:  Isr Med Assoc J       Date:  2002-11       Impact factor: 0.892

5.  A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation.

Authors:  Wilburn E Reddick; John O Glass; Kathleen J Helton; James W Langston; Chin-Shang Li; Ching-Hon Pui
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

6.  Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children.

Authors:  Michael J Fisher; Zarir P Khademian; Erin M Simon; Robert A Zimmerman; Larissa T Bilaniuk
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

7.  Methotrexate treatment protocols and the central nervous system: significant cure with significant neurotoxicity.

Authors:  A Shuper; B Stark; L Kornreich; I J Cohen; S Aviner; A Steinmetz; J Stein; Y Goshen; I Yaniv
Journal:  J Child Neurol       Date:  2000-09       Impact factor: 1.987

Review 8.  Biochemical and clinical aspects of methotrexate neurotoxicity.

Authors:  Sandra Vezmar; Achim Becker; Udo Bode; Ulrich Jaehde
Journal:  Chemotherapy       Date:  2003-05       Impact factor: 2.544

Review 9.  Chemotherapy-induced neuropathy.

Authors:  Anthony J Windebank; Wolfgang Grisold
Journal:  J Peripher Nerv Syst       Date:  2008-03       Impact factor: 3.494

Review 10.  Cisplatin-induced encephalopathy and seizures.

Authors:  N Steeghs; F E de Jongh; P A E Sillevis Smitt; M J van den Bent
Journal:  Anticancer Drugs       Date:  2003-07       Impact factor: 2.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.